Nexpoint Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-37,000	Closed	-$268K	–	149
2022 Q2	$268K	Hold	37,000	–	–	0.02%	113
2022 Q1	$478K	Hold	37,000	–	–	0.06%	95
2021 Q4	$591K	Hold	37,000	–	–	0.08%	118
2021 Q3	$595K	Hold	37,000	–	–	0.1%	100
2021 Q2	$512K	Hold	37,000	–	–	0.11%	91
2021 Q1	$541K	Sell	37,000 -3,000	-8%	-$43.9K	0.14%	83
2020 Q4	$695K	Sell	40,000 -30,000	-43%	-$521K	0.23%	88
2020 Q3	$1.28M	Sell	70,000 -42,385	-38%	-$777K	0.29%	66
2020 Q2	$2.01M	Sell	112,385 -5,000	-4%	-$89.3K	0.45%	41
2020 Q1	$1.9M	Sell	117,385 -7,440	-6%	-$121K	0.36%	40
2019 Q4	$2.25M	Hold	124,825	–	–	0.17%	70
2019 Q3	$2.53M	Buy	+124,825	New	+$2.53M	0.16%	81